advertisement
Lu Y 13
Showing records 1 to 13 | Display all abstracts from Lu Y109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Lu Y
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Du J
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Ji Z
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Qian T
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Jia J
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Lu Y
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Shi R
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Zhou W; Xu X
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Liu Y
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Zhang C
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Shu Q; Lu F
Biotechnology & genetic engineering reviews 2023; 0: 1-20
109403 SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation
Zhang J; Zhang Z
Experimental Cell Research 2023; 429: 113649
109437 Progress in clinical characteristics of high myopia with primary open-angle glaucoma
Ge T; He Y
Biotechnology & genetic engineering reviews 2023; 0: 1-20
